FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1246-1247 October 22, 1998 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Blaum, J. M. PubMed Citation

To the Editor: Blaum and Omura (June 11 issue)¹ report that they treated a case of cutaneous larva migrans with topical liquid-nitrogen cryotherapy. Apart from cryotherapy, various other therapeutic approaches have been used for this condition, including topical administration of thiabendazole and systemic administration of albendazole, thiabendazole, and ivermectin.^2,3,4,5 Since freezing is often ineffective and not devoid of side effects,^3,4 we conducted a prospective study of ivermectin, administered as a single oral dose of 12 mg, to travelers who had returned from various tropical or subtropical destinations.

From 1993 to 1997, we treated 67 consecutive outpatients who had one or . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Micantonio, T. MD, Peris, K. MD (2008). Pruritic, serpiginous eruption in a returning traveller. CMAJ 179: 51-52 [Full Text]  
• Shinkar, R M, Stocks, R, Thomas, E (2005). Cutaneous larva migrans, creeping eruption, sand worm. Arch. Dis. Child. 90: 998-998 [Full Text]  
• del Giudice, P., Marty, P. (1999). Ivermectin: A New Therapeutic Weapon in Dermatology?. Arch Dermatol 135: 705-706 [Full Text]